Peptide Atlas · Peptide

Vilon

Vilon is the dipeptide Lys-Glu; in mice given the carcinogen 1,2-dimethylhydrazine, tumours developed in 14.3% of treated animals against 60% of controls.

preclinical

provisional
PubChem 7010502
2 citations
0 discussions
0 followers
KE dipeptide
Lysylglutamate
Lysylglutamic acid
Normophthal

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

preclinical — animal, cell or mechanistic work — not yet about people

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

Evidence, kept apart

The Atlas never mixes evidence types into one blob. Each claim below carries the tier it actually sits in; an unresolved citation is shown and does not move the page.

Evidence map for Vilon. Tier reflects study design, not enthusiasm.
Claim	Tier	Source
Thymic dipeptide Lys-Glu in ageing CBA mice	preclinical	pmid 11163623
Vilon (Lys-Glu) and chemically induced neoplasia in mice (Russian-language journal)	preclinical	pmid 16308980

Unanswered questions

No open questions on file. Either everything about this molecule is known, or nobody has admitted what is not.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.